هل أنت مستخدم جديد؟ قم بالتسجيل الآن
تسجيل الدخول
| إنشاء حساب
close
AXONE - 1g - 10
| التصنيف العلاجي | أساسي / جنيسي | التركيبة العلمية | الرمز | رقم التسجيل | الاسم | العيار | حجم العبوة | الشكل الصيدلاني | طريقة الاستعمال | الوكيل | مختبر | بلد التصنيع | سعر المبيع من العموم | هامش ربح الصيدلي | الشريحة | الجهة المسؤولة | البلد المسؤول | تاريخ المؤشر |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| J01DD04 | G | Ceftriaxone (sodium) - 1g | 755 | 208619/03 | AXONE | 1g | 10 | Injectable powder for solution | Infusion/IV | Picomed SARL | Pharma International Co | Jordan | 2,852,970 L.L | 23.08 | B | 2/1/2023 |
أدوية ذات تركيبة مماثلة
| التصنيف العلاجي | أساسي / جنيسي | التركيبة العلمية | الرمز | رقم التسجيل | الاسم | العيار | حجم العبوة | الشكل الصيدلاني | طريقة الاستعمال | الوكيل | مختبر | بلد التصنيع | سعر المبيع من العموم | هامش ربح الصيدلي | الشريحة | الجهة المسؤولة | البلد المسؤول | تاريخ المؤشر |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| J01DD04 | G | Ceftriaxone (sodium) - 1g | 9696 | 67018/1 | AXONE 1G IM | 1g | 1+1 | Injectable powder for solution+diluent | IM | Picomed SARL | Pharma International Co | Jordan | 322,567 L.L | 23.08 | A1 | Pharma International Co | Jordan | 2/1/2023 |
| J01DD04 | G | Ceftriaxone - 1g | 8518 | 168015/1 | CEFTRIAXON LABATEC | 1g | 10 | Injectable powder for solution | IV/IM | UPO S.A.L. | Hikma Farmaceutica (Portugal) SA | Portugal | 2,347,835 L.L | 23.08 | B | Labatec Pharma SA | Switzerland | 2/1/2023 |
| J01DD04 | G | Ceftriaxone (sodium) - 1g | 2271 | 973948/02 | CEFTRIAXONE PANPHARMA | 1g | 25 | Injectable powder for solution | Infusion/IV/IM | Pharmacie Minapharm Halabi | Panpharma | France | 5,635,307 L.L | 21.26 | C | Panpharma | France | 2/1/2023 |
| J01DD04 | G | Ceftriaxone (sodium) - 1g | 6784 | 97385/12 | LEBACEF | 1g | 1 x 10ml | Injectable powder for solution+diluent | IV | Raymond Georges Abou Adal & Co | Mitim SRL Italy for Arwan Pharmaceutical Industries Lebanon SAL | Lebanon | 309,729 L.L | 23.08 | A2 | 2/1/2023 | ||
| J01DD04 | G | Ceftriaxone (sodium) - 1g, Lidocaine (ampoule) - | 6785 | 97384/12 | LEBACEF | 1g | 1 x 3.5ml | Injectable powder for solution+diluent | IM | Raymond Georges Abou Adal & Co | Mitim SRL Italy for Arwan Pharmaceutical Industries Lebanon SAL | Lebanon | 306,486 L.L | 23.08 | A2 | 2/1/2023 | ||
| J01DD04 | G | Ceftriaxone (sodium) - 1g | 6892 | 97493/12 | LEBACEF | 1g | 10 | Injectable powder for solution | IV/IM | Raymond Georges Abou Adal & Co | Mitim SRL Italy for Arwan Pharmaceutical Industries Lebanon SAL | Lebanon | 2,918,916 L.L | 23.08 | B | 2/1/2023 | ||
| J01DD04 | G | Ceftriaxone (sodium) - 1g | 7617 | 45614/1 | LEBACEF | 1g | 1 x 10ml | Injectable powder for solution+diluent | IV | Raymond Georges Abou Adal & Co | Mitim SRL Italy for Arwan Pharmaceutical Industries Lebanon SAL | Lebanon | 309,729 L.L | 23.08 | A2 | 2/1/2023 | ||
| J01DD04 | G | Ceftriaxone - 1g | 10075 | 152519/1 | LEBACEF | 1g | 1+1 | Injectable sterile powder for solution + lidocaine solvent | IM | Raymond Georges Abou Adal & Co | Mitim SRL Italy for Arwan Pharmaceutical Industries Lebanon SAL | Lebanon | 306,486 L.L | 23.08 | A2 | 2/1/2023 | ||
| J01DD04 | G | Ceftriaxone - 1g | 10928 | 50622/1 | LEBACEF | 1g | 1+1 | Injectable sterile powder for solution + lidocaine solvent | IM | Raymond Georges Abou Adal & Co | ACS Dobfar SpA, Italy for Arwan Pharmaceutical Industries Lebanon SAL | Lebanon | 306,486 L.L | 23.08 | A2 | 2/1/2023 | ||
| J01DD04 | G | Ceftriaxone (sodium) - 1g | 10929 | 50422/1 | LEBACEF | 1g | 1 | Injectable powder for solution+diluent | IV | Raymond Georges Abou Adal & Co | ACS Dobfar SpA, Italy for Arwan Pharmaceutical Industries Lebanon SAL | Lebanon | 309,729 L.L | 23.08 | A2 | 2/1/2023 | ||
| J01DD04 | G | Ceftriaxone (sodium) - 1g | 10930 | 50222/1 | LEBACEF | 1g | 10 | Injectable powder for solution | IV/IM | Raymond Georges Abou Adal & Co | ACS Dobfar SpA, Italy for Arwan Pharmaceutical Industries Lebanon SAL | Lebanon | 2,918,916 L.L | 23.08 | B | 2/1/2023 | ||
| J01DD04 | G | Ceftriaxone (sodium) - 1g | 10931 | 50522/1 | LEBACEF | 1g | 1 x 10ml | Injectable powder for solution+diluent | IV | Raymond Georges Abou Adal & Co | ACS Dobfar SpA, Italy for Arwan Pharmaceutical Industries Lebanon SAL | Lebanon | 309,729 L.L | 23.08 | A2 | 2/1/2023 | ||
| J01DD04 | G | Ceftriaxone (sodium) - 1g, Lidocaine (ampoule) - | 10932 | 50322/1 | LEBACEF | 1g | 1 x 3.5ml | Injectable powder for solution+diluent | IM | Raymond Georges Abou Adal & Co | ACS Dobfar SpA, Italy for Arwan Pharmaceutical Industries Lebanon SAL | Lebanon | 306,486 L.L | 23.08 | A2 | 2/1/2023 | ||
| J01DD04 | G | Ceftriaxone (disodium) - 1g | 5201 | 194126/05 | MEDAXONUM | 1g | 1 | Injectable powder for solution+diluent | IM | New Allpharma | Medochemie Ltd | Cyprus | 322,567 L.L | 23.08 | A1 | Medochemie Ltd | Cyprus | 2/1/2023 |
| J01DD04 | G | Ceftriaxone (disodium) - 1g | 6912 | 96709/12 | MEDAXONUM | 1g | 50 | Injectable powder for solution | IM | New Allpharma | Medochemie Ltd | Cyprus | 10,898,106 L.L | 19.35 | D | Medochemie Ltd | Cyprus | 2/1/2023 |
| J01DD04 | G | Ceftriaxone (disodium 3.5 hydrate) - 1g | 9144 | 161716/1 | MEGION | 1g | 1 x 10ml | Injectable powder for solution+diluent | Infusion/IV/IM | Khalil Fattal & Fils S.A.L. | Pharmaline Licensed by Sandoz GmbH, KUNDL, Austria | Lebanon | 366,030 L.L | 23.08 | A1 | 2/1/2023 | ||
| J01DD04 | G | Ceftriaxone - 1g/3.5ml, Lidocaine (ampoule) - | 7818 | 69714/1 | MEGION-A | 1g/3.5ml | 1 x 3.5ml | Injectable powder + solvent | IM | Khalil Fattal & Fils S.A.L. | Pharmaline under license from Sandoz GmbH, Austria | Lebanon | 397,486 L.L | 23.08 | A1 | 2/1/2023 | ||
| J01DD04 | G | Ceftriaxone (sodium) - 1g | 7923 | 106514/1 | MESPORIN-1000 IM | 1,000mg | 1 x 3.5ml | Injectable powder for solution+diluent | IM | Mectapharm S.A.L. | Labesfal Laboratorios Almiro SA | Portugal | 294,189 L.L | 23.08 | A1 | Acino AG | Germany | 2/1/2023 |
| J01DD04 | G | Ceftriaxone (sodium) - 1g | 7779 | 87414/1 | MESPORIN-1000 IV | 1,000mg | 1 x 10ml | Injectable powder for solution+diluent | Infusion/IV | Mectapharm S.A.L. | Labesfal Laboratorios Almiro SA | Portugal | 294,189 L.L | 23.08 | A1 | Acino AG | Germany | 2/1/2023 |
| J01DD04 | B | Ceftriaxone (sodium) - 1g | 1570 | 25468 | ROCEPHIN IV | 1g | 1 x 10ml | Injectable lyophilised powder for solution+diluent | Infusion/IV | Omnipharma | F. Hoffmann La Roche Ltd | Switzerland | 559,053 L.L | 23.08 | A2 | 2/1/2023 | ||
| J01DD04 | B | Ceftriaxone (sodium) - 1g | 1571 | 25465 | ROCEPHIN IM | 1g | 1 x 3.5ml | Injectable lyophilised powder for solution+diluent | IM | Omnipharma | F. Hoffmann La Roche Ltd | Switzerland | 538,243 L.L | 23.08 | A2 | 2/1/2023 | ||
| J01DD04 | G | Ceftriaxone - 1g | 9127 | 187458/13 | ROCICARE | 1g | 50 | Injectable powder for solution | IV/IM | Mediterranean Pharmaceutical Company | Swiss Exports PVT - Ltd | India | 6,604,133 L.L | 21.26 | C | Swiss Exports PVT - Ltd | India | 2/1/2023 |
| J01DD04 | G | Ceftriaxone (sodium) - 1g | 3263 | 208382/02 | TRAVILAN IM | 1g | 1 x 3.5ml | Injectable lyophilised powder for solution+diluent | IM | Medi drug International SAL (MDI) | Anfarm Hellas SA | Greece | 322,567 L.L | 23.08 | A1 | 2/1/2023 | ||
| J01DD04 | G | Ceftriaxone (sodium) - 1g, Lidocaine (ampoule) - | 8845 | 90816/1 | TRIACEFAN | 1+1 | Injectable powder for solution+diluent | IM/SC | New Europharm | LDP Laboratorios Torlan, SA | Spain | 363,243 L.L | 23.08 | A1 | Laboratoires Gerda | France | 2/1/2023 | |
| J01DD04 | G | Ceftriaxone (sodium) - 1g | 8846 | 105416/1 | TRIACEFAN | 1g | 1+1 | Injectable powder for solution+diluent | IV/SC | New Europharm | LDP Laboratorios Torlan, SA | Spain | 363,243 L.L | 23.08 | A1 | Laboratoires Gerda | France | 2/1/2023 |
| J01DD04 | G | Ceftriaxone (sodium) - 1g | 9334 | 98017/1 | TRIACEFAN | 1g | 100 | Injectable powder for solution | IV/SC | New Europharm | LDP Laboratorios Torlan, SA | Spain | 23,541,396 L.L | 19.35 | D | Laboratoires Gerda | France | 2/1/2023 |
| J01DD04 | G | Ceftriaxone (sodium) - 1g | 1617 | 236978/99 | TRIAXONE | 1g | 1 | Injectable powder for solution | IM | Pharmanet Drugstore S.A.R.L. | Julphar | United Arab Emirates | 322,567 L.L | 23.08 | A1 | 2/1/2023 | ||
| J01DD04 | G | Ceftriaxone (sodium) - 1g | 5716 | 219715/09 | TRIAXONE | 1g | 10 | Injectable powder for solution | IV/IM | Pharmanet Drugstore S.A.R.L. | Julphar | United Arab Emirates | 3,289,997 L.L | 23.08 | B | 2/1/2023 | ||
| J01DD04 | G | Ceftriaxone (sodium) - 1g | 2332 | 974033/02 | VERACOL | 1g | 1 x 10ml | Injectable lyophilised powder for solution+diluent | Infusion/IV | Macromed S.A.R.L. | Demo SA | Greece | 334,865 L.L | 23.08 | A1 | 2/1/2023 |
Sitemap
حقوق الطبع والنشر محفوظة ل وزارة الصحة العامة ©2023